Statistics at a Glance
At a Glance
Estimated New Cases in 2020 1,806,590
% of All New Cancer Cases 100.0%
Estimated Deaths in 2020 606,520
% of All Cancer Deaths 100.0%
|Year||Rate of New Cases — SEER 9||Rate of New Cases — SEER 13||Death Rate — U.S.||5-Year Relative Survival — SEER 9|
|Observed||Modeled Trend||Observed||Modeled Trend||Observed||Modeled Trend||Observed||Modeled Trend|
New cases come from SEER 13. Deaths come from U.S. Mortality.
All Races, Both Sexes. Rates are Age-Adjusted.
Modeled trend lines were calculated from the underlying rates using the Joinpoint Trend Analysis Software.
New cases are also referred to as incident cases in other publications. Rates of new cases are also referred to as incidence rates.
Rate of New Cases and Deaths per 100,000: The rate of new cases of cancer of any site was 442.4 per 100,000 men and women per year. The death rate was 155.5 per 100,000 men and women per year. These rates are age-adjusted and based on 2013–2017 cases and 2014–2018 deaths.
Lifetime Risk of Developing Cancer: Approximately 39.5 percent of men and women will be diagnosed with cancer of any site at some point during their lifetime, based on 2015–2017 data.
Prevalence of This Cancer: In 2017, there were an estimated 15,760,939 people living with cancer of any site in the United States.
How Many People Survive 5 Years Or More after Being Diagnosed with Cancer of Any Site?
Relative survival is an estimate of the percentage of patients who would be expected to survive the effects of their cancer. It excludes the risk of dying from other causes. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.
Based on data from SEER 18 2010–2016. Gray figures represent those who have died from cancer of any site. Green figures represent those who have survived 5 years or more.
New Cases and Deaths
How Common Is This Cancer?
|Rank||Common Types of Cancer||Estimated New
|1.||Breast Cancer (Female)||276,480||42,170|
|2.||Lung and Bronchus Cancer||228,820||135,720|
|5.||Melanoma of the Skin||100,350||6,850|
|8.||Kidney and Renal Pelvis Cancer||73,750||14,830|
|Cancer of Any Site||1,806,590||606,520|
In 2020, it is estimated that there will be 1,806,590 new cases of cancer of any site and an estimated 606,520 people will die of this disease.
Who Gets This Cancer?
Overall cancer incidence rates are higher among men than women. Among racial/ethnic groups, there are more new cases among African American men and white women and fewer new cases among Asian/Pacific Islanders of both sexes. The rate of new cases of cancer of any site was 442.4 per 100,000 men and women per year based on 2013–2017 cases, age-adjusted.
|American Indian/Alaska Native||321.0|
|American Indian/Alaska Native||305.9|
SEER 21 2013–2017, Age-Adjusted
|Age Range||Percent of New Cases|
Cancer of any site is most frequently diagnosed among people aged 65–74.
SEER 21 2013–2017, All Races, Both Sexes
Who Dies From This Cancer?
Death rates for cancer are higher among the middle-aged and elderly populations. The death rate was 155.5 per 100,000 men and women per year based on 2014–2018 deaths, age-adjusted.
|American Indian/Alaska Native||169.3|
|American Indian/Alaska Native||120.1|
U.S. 2014–2018, Age-Adjusted
|Age Range||Percent of Deaths|
The percent of cancer of any site deaths is highest among people aged 65–74.
U.S. 2014–2018, All Races, Both Sexes
Trends in Rates
Changes Over Time
Keeping track of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.
Using statistical models for analysis, age-adjusted rates for new cancer of any site cases have been falling on average 1.1% each year over 2008–2017. Age-adjusted death rates have been falling on average 1.7% each year over 2009–2018. 5-year relative survival trends are shown below.
Interactive Statistics with SEER*Explorer
- Create custom graphs and tables
- Download data and images
- Share links to results
SEER*Explorer is an interactive website that provides easy access to a wide range of SEER cancer statistics. It provides detailed statistics for a cancer site by gender, race, calendar year, age, and for a selected number of cancer sites, by stage and histology.Explore Additional Cancer of Any Site Statistics
More About This Cancer
Here are some resources for learning more about cancer.
- Learn more about cancer
- More about risk factors for cancer
- More about symptoms and diagnosis of cancer
- More about treatment options for cancer
- More about clinical trials
- More about cancer prevention
All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within SEER*Explorer.
All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.
SEER Cancer Stat Facts: Cancer of Any Site. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/all.html
These stat facts focus on population statistics that are based on the U.S. population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse SEER*Explorer. To see statistics for a specific state, go to the State Cancer Profiles.
The statistics presented in these stat facts are based on the most recent data available, most of which can be found in SEER*Explorer. In some cases, different year spans may be used.
Estimates of new cases and deaths for 2020 are projections made by the American Cancer Society (ACS), based on earlier reported data.
Cancer is a complex topic. There is a wide range of information available. These stat facts do not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although links are provided to information in many of these areas.